Electromed outlines $1.05M-$1.15M fiscal 2027 home care revenue per rep target while CEO plans April 2027 retirement
At a glance
- $ELMD today−5.02%last $23.10
- Vs industry peers−4.07 pts6-peer median −0.94% · far behind
- Since Aug 25−27.3%from the first trade after the story
- 52-week range1.7% above low$22.72 – $47.40
- Last reported profit$2.8Mquarter to Sep 30, 2026 · 10-Q
- In the headline$1.05 millionAmount
Nothing reported about electromed across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.
Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.
What it means
- What to watch: This one turns on a concrete figure ($1); set it against the recent trend before reading it as a turning point.
- How the stock is trading: $ELMD -5.02% in the latest session.
- Timing: It came out after the closing bell. The session change shown was settled before the story existed, and the next session is the first that could react.
Where the stock stands
Electromed ($ELMD) fell 5.02% to $23.10 in the latest session. Over the past month it is down 15.7%. That leaves it 51% below its 52-week high of $47.40 and 1.7% above its low of $22.72, close to the bottom of its range. It has been a volatile year: the high was 2.1 times the low, so moves this size are not unusual for it.
What the filings say
In its latest report (10-Q, filed Nov 10, 2026), $ELMD earned $2.8M over the quarter to Sep 30, 2026 on revenue of $18.7M. Operations brought in $373K of cash over the quarter to Sep 30, 2026; after capital spending, free cash flow was $208K. Total liabilities were $8.6M against $15.9M of cash on Sep 30, 2026. The company filed an 8-K — the form for material events — on Aug 25, the same day as this story; it is $ELMD's own account and the first thing to read. Figures are as filed with the SEC; the $ELMD page has the full statements.
How much coverage it is getting
This story is more than a month old. Since then Wook has filed 2 newer stories on Electromed in the last 30 days, 2 of them this week. By their wording, 0 read bullish, 2 neutral and 0 bearish.
The bigger picture
With earnings, the number matters less than the number versus expectations — and guidance often matters more than both. A beat paired with a soft outlook can still get a cold reception. Wook's supply-chain scanner shows no unusual stress in Health Care today.
What to watch next
The company's own filings are the primary source. Its latest SEC reports, including any filing on a material event, are on the $ELMD page, and they say what management has disclosed without a reporter in between. Reading how two or three outlets frame the same story is the quickest way to separate the facts from the angle. Wook AI, at the top of the page, can work out how far $ELMD is from its high or compare this week's coverage with earlier weeks.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Seeking Alpha published this on August 25, 2026. $ELMD has moved -27.29% ($31.77 to $23.10). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.
